Skeletal Health of Klinefelter Patients
Primary Purpose
Osteoporosis
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
dual-energy X-ray absorptiometry
Sponsored by
About this trial
This is an interventional screening trial for Osteoporosis focused on measuring Klinefelter, Osteoporosis, dual-energy X-ray absorptiometry
Eligibility Criteria
Inclusion Criteria:
- diagnosis of klinefelter
Exclusion Criteria:
- klinefelter subjects with a history of hip or waist surgery or trauma
- for control group with known bone disease, unknown fertility hypogonadism findings on physical examination (e.g. low testicular volume or abnormal body hair), known hypogonadism, previous androgen replacement therapy any drug therapy affecting bone metabolism
Sites / Locations
- Department of Urology, Ercieys University, Faculty Of Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Klinefelter
Control
Arm Description
Male patients followed with the diagnosis of klinefelter
healthy male subjects
Outcomes
Primary Outcome Measures
BMD
bone mineral density
Secondary Outcome Measures
Full Information
NCT ID
NCT03704987
First Posted
October 10, 2018
Last Updated
October 11, 2018
Sponsor
TC Erciyes University
1. Study Identification
Unique Protocol Identification Number
NCT03704987
Brief Title
Skeletal Health of Klinefelter Patients
Official Title
Skeletal Health of Klinefelter Patients is Not so Bad
Study Type
Interventional
2. Study Status
Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
January 1, 2015 (Actual)
Primary Completion Date
July 31, 2017 (Actual)
Study Completion Date
August 31, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
TC Erciyes University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study compared the bone health of KS patients who were actively monitored in our clinic by dual-energy X-ray absorptiometry (DXA) with that of a control group of healthy volunteers.
Detailed Description
Klinefelter syndrome (KS) is the most common chromosome number abnormality of men, occurring in 1/500 to 1/1000 live births . It was first described in 1942 as an endocrine disorder characterised by small, hard testicles androgen deficiency, gynaecomastia and increased follicle stimulating hormone (FSH). Osteoporosis is a progressive bone remodelling disorder in which bone loss exceeds bone formation. The resulting micro-architectural defects and bone fragility are associated with increased fracture risk and mortality. In KS, testosterone deficiency is associated with decreased bone mass and low bone mineral density (BMD) , and a positive correlation of total serum testosterone and BMD has been reported . There are some exceptions ; however, most studies have reported that KS increases the risk of osteopenia and osteoporosis compared with age-matched control groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoporosis
Keywords
Klinefelter, Osteoporosis, dual-energy X-ray absorptiometry
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
To compare bone mineral density of klinefelter patients and normal population
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
247 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Klinefelter
Arm Type
Active Comparator
Arm Description
Male patients followed with the diagnosis of klinefelter
Arm Title
Control
Arm Type
Active Comparator
Arm Description
healthy male subjects
Intervention Type
Diagnostic Test
Intervention Name(s)
dual-energy X-ray absorptiometry
Intervention Description
dual-energy X-ray absorptiometry
Primary Outcome Measure Information:
Title
BMD
Description
bone mineral density
Time Frame
T score obtained from dual-energy X-ray absorptiometry through study completion, an average of 2 years
10. Eligibility
Sex
Male
Gender Based
Yes
Gender Eligibility Description
Male patiens
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
diagnosis of klinefelter
Exclusion Criteria:
klinefelter subjects with a history of hip or waist surgery or trauma
for control group with known bone disease, unknown fertility hypogonadism findings on physical examination (e.g. low testicular volume or abnormal body hair), known hypogonadism, previous androgen replacement therapy any drug therapy affecting bone metabolism
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Abdullah Demirtas, MD
Organizational Affiliation
Erciyes University Faculty of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Urology, Ercieys University, Faculty Of Medicine
City
Kayseri
ZIP/Postal Code
38039
Country
Turkey
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
18832949
Citation
Paduch DA, Fine RG, Bolyakov A, Kiper J. New concepts in Klinefelter syndrome. Curr Opin Urol. 2008 Nov;18(6):621-7. doi: 10.1097/MOU.0b013e32831367c7.
Results Reference
background
PubMed Identifier
10782361
Citation
Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000 Apr;21(2):115-37. doi: 10.1210/edrv.21.2.0395.
Results Reference
background
PubMed Identifier
20231569
Citation
Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, Boonen S. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010 Mar 16;152(6):380-90. doi: 10.7326/0003-4819-152-6-201003160-00008.
Results Reference
background
PubMed Identifier
10093980
Citation
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999 Mar 13;353(9156):878-82. doi: 10.1016/S0140-6736(98)09075-8.
Results Reference
background
PubMed Identifier
21183376
Citation
Maravic M, Taupin P, Landais P, Roux C. Decrease of inpatient mortality for hip fracture in France. Joint Bone Spine. 2011 Oct;78(5):506-9. doi: 10.1016/j.jbspin.2010.11.006. Epub 2010 Dec 22.
Results Reference
background
PubMed Identifier
18458282
Citation
Liu H, Paige NM, Goldzweig CL, Wong E, Zhou A, Suttorp MJ, Munjas B, Orwoll E, Shekelle P. Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline. Ann Intern Med. 2008 May 6;148(9):685-701. doi: 10.7326/0003-4819-148-9-200805060-00009.
Results Reference
background
PubMed Identifier
20348548
Citation
Ferlin A, Schipilliti M, Di Mambro A, Vinanzi C, Foresta C. Osteoporosis in Klinefelter's syndrome. Mol Hum Reprod. 2010 Jun;16(6):402-10. doi: 10.1093/molehr/gaq026. Epub 2010 Mar 27.
Results Reference
background
PubMed Identifier
8167626
Citation
Eulry F, Bauduceau B, Lechevalier D, Magnin J, Flageat J, Gautier D. [Early spinal bone loss in Klinefelter syndrome. X-ray computed tomographic evaluation in 16 cases]. Rev Rhum Ed Fr. 1993 Apr;60(4):287-91. French.
Results Reference
background
PubMed Identifier
8924228
Citation
Choi HR, Lim SK, Lee MS. Site-specific effect of testosterone on bone mineral density in male hypogonadism. J Korean Med Sci. 1995 Dec;10(6):431-5. doi: 10.3346/jkms.1995.10.6.431.
Results Reference
background
PubMed Identifier
6832705
Citation
Foresta C, Ruzza G, Mioni R, Meneghello A, Baccichetti C. Testosterone and bone loss in Klinefelter syndrome. Horm Metab Res. 1983 Jan;15(1):56-7. doi: 10.1055/s-2007-1018630. No abstract available.
Results Reference
background
PubMed Identifier
8695968
Citation
Luisetto G, Mastrogiacomo I, Bonanni G, Pozzan G, Botteon S, Tizian L, Galuppo P. Bone mass and mineral metabolism in Klinefelter's syndrome. Osteoporos Int. 1995;5(6):455-61. doi: 10.1007/BF01626608.
Results Reference
background
PubMed Identifier
21126728
Citation
Hieronimus S, Lussiez V, Le Duff F, Ferrari P, Bstandig B, Fenichel P. Klinefelter's syndrome and bone mineral density: is osteoporosis a constant feature? Ann Endocrinol (Paris). 2011 Feb;72(1):14-8. doi: 10.1016/j.ando.2010.10.002. Epub 2010 Dec 3.
Results Reference
background
Learn more about this trial
Skeletal Health of Klinefelter Patients
We'll reach out to this number within 24 hrs